Kedrion SpA Sustainability Reports
Kedrion S.p.A. is an international biopharmaceutical company specializing in the collection of human plasma and the development, production, and distribution of plasma-derived therapies. The company focuses on treating rare, serious, and life-threatening conditions such as hemophilia and immunodeficiencies.
Sector: Manufacturing
Country: Italy
Exchange: Unlisted
LEI: 81560047FA58E1BEDF67
15 reports from 2012 to 2025
